Drugmaker Cephalon Completes $443.9M Settlement With DOJ, States Related To Allegations Of Improper Sales, Marketing Practices
Oct 3rd 2008Drug InformationHealth Insurance / Medical Insurance
Cephalon on Monday completed a $443.9 million settlement with federal and state regulators related to allegations of improper sales and marketing practices, the Wall Street Journal reports. Under the settlement, first disclosed in November 2007, Cephalon agreed with the Office of the U.S. attorney in Philadelphia and the
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
